MEMBER EXCLUSIVE

Lessons from the Ebola crisis

Healthcare professionals have learned a great deal about creating effective care environments that allow for the safe treatment of patients with EVD and other infectious diseases.

Sign up and start learning today

Lophius Biosciences Appoints Robert J. Silverman as Supervisory Board Member

March 29, 2017

Lophius Biosciences GmbH, a privately held biotech company focusing on the development and marketing of innovative T cell-based diagnostic systems, today announced that Robert J. Silverman, former CEO of mtm Laboratories AG, was appointed to the Company’s Supervisory Board.

Mr. Silverman has over 30 years of leadership experience in private and public companies across multiple segments of the healthcare industry. Currently he serves on the board of several early stage companies, including Chairman of Kiyatec, Inc., and as an Operational Partner with Gilde Healthcare, which recently closed a $285 Million fund. Mr. Silverman has considerable executive level experience in the diagnostic and pharmaceutical industry from his previous roles at Abbott Laboratories, Pasteur Merieux Connaught, Cytyc Corporation and mtm Laboratories. At mtm laboratories, an in vitro diagnostic company developing and commercializing tests for the detection and diagnosis of cervical cancer, he was instrumental as CEO in creating a successful business enterprise that resulted in the acquisition by Roche for $270 Million. He received his Bachelor of Science degree in Pharmacy from the University of Michigan, and a Master in Management from the JL Kellogg Graduate School of Management.

“On behalf of Lophius, I am pleased to welcome Bob on board. Bob has extraordinary business and operational expertise. Management and the board will greatly benefit from his broad experience as a value creating executive and as a strategic advisor in the diagnostic industry”, said Prof. Ralf Wagner, Chairman of the Lophius Biosciences Supervisory Board.

“The disruptive and proprietary technology platforms of Lophius enable the development of novel solutions in the emerging field of T cell based diagnostics. The potential exists to address significant unmet market needs, and this is greatly facilitated by the extended funding. I look forward to being a part of this exciting opportunity and to support this effort”, commented Bob Silverman, Member of the Lophius Biosciences Supervisory Board.

See the latest posts on our homepage


Share

Topic Area: Press Release


Recent Posts
Recent Posts

Woman who gave birth in Japan photographs hospital meals


Meals look more than restaurant-worthy

10/20/2017

Focus: Infection Control

Debunking the assumptions around proper hand hygiene


Hand hygiene in healthcare involves not only washing hands with soap and water, but also the use of alcohol-based hand sanitizers

10/20/2017

Hospital ship off Puerto Rico sits mostly idle 2 weeks after its arrival


Only 33 of the 250 beds on the Comfort — 13 percent — are being used

10/20/2017

Focus: Facility Design

Today's medical office design emphasizes efficiency and aesthetics


New facilities offer patients a tranquil, relaxing and beautiful environment

10/20/2017

Critical Facilities Summit includes Medical, Labs, and Life-Safety Day


The 5th annual Critical Facilities Summit will be held in Minneapolis, Oct. 23-35.

10/20/2017





Post Comment




FREE
NEWSLETTER

• News and Updates
• Webcast Alerts
• Building Technologies



All fields are required.